Log in
Enquire now
CureGenetics

CureGenetics

CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.

OverviewStructured DataIssuesContributors

Contents

curegenetics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Molecular diagnostics
Molecular diagnostics
Gene therapy
Gene therapy
Cell therapy
Cell therapy
Healthcare
Healthcare
CRISPR
CRISPR
‌
Genome editing
Biomedical engineering
Biomedical engineering
...
Location
Suzhou
Suzhou
China
China
CEO
‌
Yuanyuan Xu
Founder
‌
Yuanyuan Xu
Date Incorporated
2016
Investors
QiMing Venture Partners
QiMing Venture Partners
Founded Date
2016
Total Funding Amount (USD)
34,000,000
Latest Funding Round Date
August 6, 2018
Latest Funding Type
Series A
Series A
Country
China
China
Headquarters
Suzhou
Suzhou

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
17,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Cure Genetics Closes $17M Financing Round

Staff reporter

https://www.genomeweb.com/molecular-diagnostics/cure-genetics-closes-17m-financing-round#.XJOU6BNKh-U

Web

References

Find more companies like CureGenetics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.